---
title: "《業績》透雲生物中期純利 1,124 萬元  虧轉盈"
description: "透雲生物公佈 6 月止六個月中期業績，收入 3,658 萬元，按年下降 20.8%。錄得純利 1,124 萬元，相較上年同期虧損 4,797 萬元，虧轉盈；每股盈利 0.4 仙。不派息。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/254321281.md"
published_at: "2025-08-24T11:26:42.000Z"
---

# 《業績》透雲生物中期純利 1,124 萬元  虧轉盈

> 透雲生物公佈 6 月止六個月中期業績，收入 3,658 萬元，按年下降 20.8%。錄得純利 1,124 萬元，相較上年同期虧損 4,797 萬元，虧轉盈；每股盈利 0.4 仙。不派息。

透雲生物 (01332.HK) 公佈 6 月止六個月中期業績，收入 3,658 萬元，按年下降 20.8%。錄得純利 1,124 萬元，相較上年同期虧損 4,797 萬元，虧轉盈；每股盈利 0.4 仙。不派息。

### Related Stocks

- [01332.HK - 透雲生物](https://longbridge.com/zh-HK/quote/01332.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| My High School Teacher Groomed Me. I Kept His Secret — Until Now. | The article recounts a woman's experience of being groomed by her high school teacher, who was significantly older. She  | [Link](https://longbridge.com/zh-HK/news/276359439.md) |
| Ence To Cut 44 Jobs At Navia Biofactory By 2027 | Ence Energia y Celulosa SA :REACHES AGREEMENT ON COLLECTIVE DISMISSAL AT NAVIA BIOFACTORYAGREEMENT INCLUDES TERMINATION  | [Link](https://longbridge.com/zh-HK/news/276430844.md) |
| Metabiomed To Cancel 2.7 Billion Won Worth Of Own Shares | Metabiomed Co Ltd :METABIOMED: TO CANCEL 2.7 BILLION WON WORTH OF OWN SHARES | [Link](https://longbridge.com/zh-HK/news/276408478.md) |
| Deep-sea fish break the mold with novel visual system | New research has identified a novel type of visual cell in deep-sea fish, blending features of rods and cones, adapted f | [Link](https://longbridge.com/zh-HK/news/276218702.md) |
| Assessing InnoCare Pharma (SEHK:9969) Valuation As Its Autoimmune Pipeline Advances Through Key Trial Milestones | InnoCare Pharma (SEHK:9969) has initiated a Phase II/III trial for its TYK2 inhibitor, soficitinib, while facing a 14.51 | [Link](https://longbridge.com/zh-HK/news/276057197.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。